Synlogic Announces Contract with the Air Force Research Lab
CAMBRIDGE, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral,...
Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral,...
Alliance Global Partners started coverage on shares of Synlogic (NASDAQ:SYBX – Free Report) in a report published on Monday, Benzinga reports. The firm issued a buy rating and a $30.00 price target on the biotechnology company’s stock. Synlogic Stock Up 5.7 % Shares of SYBX stock opened at $3.53 on Monday. The company has a […]
Poster presentation on SYNB1353 program for homocystinuria includes findings from process improvements to improve activity of methionine degradation -…
- Poster presentation on SYNB1353 program for homocystinuria includes findings from process improvements to improve activity of methionine degradation - CAMBRIDGE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Synlogic,
Synlogic, Inc. (NASDAQ:SYBX – Free Report) – Stock analysts at Chardan Capital boosted their FY2023 earnings per share (EPS) estimates for shares of Synlogic in a note issued to investors on Monday, November 13th. Chardan Capital analyst K. Nakae now forecasts that the biotechnology company will earn ($7.80) per share for the year, up from […]